Committed to providing a full range of services to pharmaceutical manufacturers, Neopharm Israel has a well-established Regulatory Affairs Department.

This team has vast experience in applying for registration and obtaining approval to market new pharmaceuticals in Israel and a thorough understanding of all the regulatory requirements of the Israeli Ministry of Health, the Regulatory Affairs Departments . By taking responsibility for this function, Neopharm accomplishes two important goals: the efforts required from foreign manufacturers in registering their products in Israel are minimized, and the regulatory approvals process is accelerated.

The team has ample experience obtaining approvals based on the information in files submitted to the FDA or EMEA.